Facebook Linkedin RSS Twitter Youtube
Home 2024

Genetic diseases

StockWatch: Wall Street’s Leaders and Laggards of 2024
GEN Edge

StockWatch: Wall Street’s Leaders and Laggards of 2024

Signal Peptide Harnesses Exosomes for Precise Drug Delivery
Drug Discovery

Signal Peptide Harnesses Exosomes for Precise Drug Delivery

StockWatch: ARK Mostly Bullish on CRISPR Therapeutics
GEN Edge

StockWatch: ARK Mostly Bullish on CRISPR Therapeutics

Gene and Cell Therapies Take Aim at Parkinson’s Disease
Drug Discovery

Gene and Cell Therapies Take Aim at Parkinson’s Disease

Going Public: Doudna’s Dream Team Launches Groundbreaking Sickle Cell Trial
GEN Edge

Going Public: Doudna’s Dream Team Launches Groundbreaking Sickle Cell Trial

Rare Genetic Disorder Helps Explain Link Between Cancer Immunotherapy and Increased Infections
Cancer

Rare Genetic Disorder Helps Explain Link Between Cancer Immunotherapy and Increased Infections

Novartis Buys Kate Therapeutics, Expanding in Neuro Gene Therapy
Drug Discovery

Novartis Buys Kate Therapeutics, Expanding in Neuro Gene Therapy

Gene Therapy for Muscular Dystrophy Could Use StitchR to Assemble XL Gene from S Segments
Genome Editing

Gene Therapy for Muscular Dystrophy Could Use StitchR to Assemble XL Gene from S Segments

ASHG 2024: Stalwarts of Human Genetics Receive Professional Awards
News

ASHG 2024: Stalwarts of Human Genetics Receive Professional Awards

Child with Rare, Genetic, Neurological Disease Receives Diagnosis, With C. elegans’ Help
News

Child with Rare, Genetic, Neurological Disease Receives Diagnosis, With C. elegans’ Help

123...88Page 1 of 88
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.